Welltower (NYSE:WELL) Price Target Raised to $170.00

Welltower (NYSE:WELL) had its price target lifted by research analysts at Mizuho from $141.00 to $170.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s price objective indicates a potential upside of 14.24% from the stock’s previous close.

A number of other equities analysts also recently issued reports on WELL. Scotiabank upped their price target on Welltower from $165.00 to $166.00 and gave the company a “sector outperform” rating in a report on Thursday, March 6th. Jefferies Financial Group upgraded Welltower from a “hold” rating to a “buy” rating and boosted their price objective for the company from $132.00 to $147.00 in a research note on Thursday, January 2nd. Wells Fargo & Company boosted their price objective on Welltower from $140.00 to $158.00 and gave the company an “equal weight” rating in a research note on Monday, March 10th. Bank of America boosted their price objective on Welltower from $221.00 to $242.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Finally, Wedbush upgraded Welltower from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $145.00 to $167.00 in a research note on Friday, February 14th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $156.46.

Welltower Stock Performance

Shares of WELL opened at $148.81 on Tuesday. The stock has a 50 day moving average price of $142.63 and a 200 day moving average price of $134.35. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $95.43 billion, a price-to-earnings ratio of 95.39, a price-to-earnings-growth ratio of 2.87 and a beta of 1.20. Welltower has a 52-week low of $87.87 and a 52-week high of $158.55.

Welltower (NYSE:WELL) last announced its quarterly earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.73. Welltower had a return on equity of 3.15% and a net margin of 11.91%. Research analysts predict that Welltower will post 4.88 EPS for the current fiscal year.

Institutional Investors Weigh In On Welltower

Large investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC grew its holdings in Welltower by 0.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 121,080 shares of the real estate investment trust’s stock worth $15,260,000 after acquiring an additional 946 shares during the period. Lansforsakringar Fondforvaltning AB publ acquired a new position in Welltower during the fourth quarter worth $25,818,000. Centaurus Financial Inc. grew its holdings in Welltower by 2,074.5% during the fourth quarter. Centaurus Financial Inc. now owns 17,135 shares of the real estate investment trust’s stock worth $2,159,000 after acquiring an additional 16,347 shares during the period. Wood Tarver Financial Group LLC acquired a new position in Welltower during the fourth quarter worth $54,000. Finally, Comprehensive Money Management Services LLC acquired a new position in Welltower during the fourth quarter worth $539,000. Hedge funds and other institutional investors own 94.80% of the company’s stock.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.